Frailty, comorbidity and survival comparisons between populations eligible for screening according to risk factor versus risk score criteria: results from the Yorkshire Lung Screening Trial
These data suggest that currently used risk models identify populations with a small increase in moderate/severe frailty and multimorbidity compared to the USPSTF<sub>2021</sub> criteria, but there is no evidence to suggest that this results in differences in 3-year overall survival.
Authors
- Philip A Crosbie
- Rebecca J Beeken
- Samuel D Relton
- Rhian Gabe
- Richard D Neal (ORCID: https://orcid.org/0000-0002-3544-2744)
- Neil Hancock
- Matthew E J Callister
- Daniel Vulkan
- Martel Brown
- Hui Zhen Tam
- Andrew Clegg
- Anas Almatrafi
- Kate E Best
Institutions
- University of Leeds (GB)
- Queen Mary University of London (GB)
- Umm al-Qura University (SA)
- University of Exeter (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Manchester Academic Health Science Centre (GB)
- University College London (GB)
Publication Details
- Journal
- Thorax
- Published
- 2026-01-27
- DOI
- https://doi.org/10.1136/thorax-2024-222487
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Umm Al-Qura University
- Manchester Biomedical Research Centre